New appointees to US vaccine advisory committee have ties to Big Pharma 
A report points out that most of ACIP’s new appointees have received grant funding or consulting fees from major pharmaceutical companies like Pfizer, Moderna, and Merck.

Mike Campbell

March 6, 2024

Nine new members appointed to America’s Advisory Committee on Immunization Practices (ACIP) have financial ties to Big Pharma, or have publicly promoted vaccines.

New appointees to US vaccine advisory committee have ties to Big Pharma 

ACIP is said to be an autonomous group of experts not affiliated with the federal government.

Children’s Health Defense reported on Wednesday massive conflict of interest concerns for the new appointees who will be advising the Centers for Disease Control and Prevention (CDC) on vaccine recommendations. 

The report points out that most of the appointees have received grant funding or consulting fees from major pharmaceutical companies like Pfizer, Moderna, and Merck:

  • Dr. Denise Jamieson: Known for promoting COVID vaccines for pregnant women and receiving funding from the CDC for COVID-19 vaccination promotion.
  • Dr. Yvonne Maldonado: Received research funding from Pfizer and advocated for testing COVID vaccines in children.
  • Dr. Robert Schechter: Serves as a public advocate on various HHS committees and has a background with the California Department of Public Health.
  • Dr. Albert Shaw: Advocated for COVID-19 vaccination and has ties to pharmaceutical companies.
  • Dr. Edwin Asturias: A global vaccine researcher with consulting fees from major pharmaceutical companies like Merck.
  • Dr. Noel Brewer: Known for developing the “Announcement Approach” to HPV vaccination and consulting for Merck.
  • Dr. Helen Chu: Has ties to pharmaceutical companies, Gates ventures, and advocates for the RSV vaccine.

The cozy relationship between Big Pharma and vaccine safety advisors isn’t anything new, of course. In December 2022, a member from Pfizer’s Independent Data Safety Monitoring Board admitted in court that she was also on the pharmaceutical company’s payroll. 

FDA removes informed consent for “minimal risk” 

Last month, the Food and Drug Administration’s (FDA) removed the requirement to get informed consent from human participants for what they call “minimal risk” studies.

The FDA claimed the policy change will provide cost savings and healthcare advances. 

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Liberal Premier says of carbon tax: “It doesn’t make sense from a logical perspective.”

TCS Wire

May 1, 2024

Trending News

“The bill that I’m going to sign today is going to say basically take your fake lab-grown meat elsewhere. We’re not doing that in the state of Florida,” DeSantis said.

TCS Wire

May 1, 2024

Trending News

Conservatives have labeled Mark Carney as “Carbon Tax Carney,” accusing him of profiting financially from the very policies he promotes.

Mike Campbell

April 30, 2024

Trending News

Viral confrontation highlights a growing concern among many that the shift towards digital-only transactions could lead to increased surveillance and control.

Mike Campbell

April 30, 2024

Trending News

The idea of expanding railways within Alberta has been floated for over a decade and a half, but Premier Danielle Smith says the time to act on a comprehensive railway plan is now, especially given the massive and historic migration to the province.

TCS Wire

April 30, 2024

Trending News

Trudeau is STILL blaming Stephen Harper for his party’s failures: “Construction takes a while.”

Mike Campbell

April 29, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.